IKOMA Technologies (531997)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 17.03% is a lone positive capital-efficiency signal, though it needs reconciliation with the reported net loss and zero sales.
• Book value of ₹4.54 per share gives at least a nominal tangible asset reference point, even if the price trades far above it.
• Paying no dividend while loss-making avoids the waste of scarce cash, though it does not compensate for the weak economics.

Concerns

• Latest quarterly sales are ₹0 Cr with a net loss of ₹-1 Cr, meaning there is currently no visible revenue-generating business.
• Piotroski F-Score of 3/9 and ROE of -14.70% point to poor financial health and continuing shareholder value destruction.
• At ₹52.93, the stock trades at 11.66 times book value of ₹4.54, with a meaningless P/E of 0.00 — valuation is disconnected from fundamentals.
• Promoter holding and debt/equity are N/A, creating a lack of transparency on ownership and leverage.

AI Analysis

I start with the first question: can I understand this business? IKOMA Technologies, an industrial products company, currently fails that test. The latest quarter shows sales of ₹0 Cr and a net loss of ₹-1 Cr. A business with no revenue and a loss is not a business I can value; it is a promise. Over the years, earnings have worsened, with profit growth at -8.77%, and the return on equity is deeply negative at -14.70%. A Piotroski score of 3 out of 9 strengthens my concern about financial health. Interestingly, ROCE is reported at 17.03%, but with a net loss and no sales, I would need a very clear explanation before treating that as an encouraging sign. Book value is only ₹4.54 per share, yet the stock trades at ₹52.93, or 11.66 times book. Graham would call that speculation, not investment. The absence of a dividend and the meaningless P/E of 0.00 tell me the market is paying for some future story, not for current economics. The 52-week range between ₹13.81 and ₹85.50 shows how violent the sentiment swings are. Without promoter holding data, I cannot judge whether management's interests are aligned with mine. In value investing, patience is useful, but only when the math supports the wait. Here the math does not. I would keep this on the watchlist, not in the wallet, and demand evidence of real sales, positive earnings, and a sane valuation before acting.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer